ISS-EVA: NTRS's weak performance (31st percentile vs. Russell 3000 companies), coupled with its high risk (76th percentile), indicates a low intrinsic valuation is warranted (21st percentile), which compared to its actual market valuation (50th percentile at its
$79.95 share price) makes for a PRVit score of 16th percentile vs. the market.
There are no replies in this thread yet. Be the first to post a reply below: